PD 0332991 and Cetuximab in Patients With Incurable SCCHN

NCT02101034 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Squamous Cell of Head and Neck

Interventions

BIOLOGICAL: Cetuximab
DRUG: PD 0332991

Sponsor

Washington University School of Medicine

Collaborators

[object Object]